Evaluation and prevention of cardioembolic stroke.
Level 5 - mechanism / opinion, no new human data
Narrative clinical review without systematic search or primary data synthesis
PubMed 24699483 · doi:10.1212/01.CON.0000446103.82420.2d
What was done
This narrative review summarizes diagnostic strategies and secondary prevention approaches for cardioembolic stroke, discussing clinical indicators (large vessel occlusion, multiple vascular territories), diagnostic testing (ECG, echocardiography, cardiac monitoring), and treatment considerations including oral anticoagulants for atrial fibrillation and other cardiac conditions.
What was found
The abstract identifies clinical triggers for cardioembolic evaluation and notes that atrial fibrillation is the most common cause justifying anticoagulation therapy. No quantitative results, sample sizes, or effect estimates are reported in the abstract.
Why it matters
It outlines clinical pathways for identifying cardiogenic sources of stroke and selecting appropriate anticoagulation strategies to prevent recurrent events.
Limits
This is an unstructured narrative review rather than a systematic review or empirical study. The abstract provides no quantitative data, search criteria, or details on the underlying evidence base.
Cited by
- supports Atrial fibrillation is the leading heart disease issue causing strokes.